Humacyte Inc
NASDAQ:HUMA 4:00:00 PM EDT
| Market Cap (Intraday) | 329.97M |
| Current PE | 9.61 |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $3.02 |
| 50-Day MA | $2.65 |
| 200-Day MA | $3.70 |
Humacyte Inc Stock, NASDAQ:HUMA
2525 East North Carolina Highway 54, Durham, North Carolina 27713
United States of America
Phone: +1.919.313.9633
Number of Employees: 146
Description
Humacyte, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason and Juliana L. Blum in October 13, 2004 and is headquartered in Durham, NC.